Replimune Group, Inc.
REPL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001737953
In the last 90 days, Replimune Group, Inc. insiders filed 0 open-market purchases and 5 sales; 199 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
Holders of 5% or more of REPL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Replimune Group, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 13D | 14.30%11.0M shares | New | Mar 7, 20251 filing | Mar 7, 2025 | SEC |
| RTW Investments, LP | 13G/A | 8.90%7.36M shares | +0.70 ppfrom 8.20% | Nov 14, 20252 filings | May 15, 2026 | SEC |
| Ridgeback Capital Investments L.P. | 13G/A | 8.70%7.31M shares | +1.10 ppfrom 7.60% | May 21, 20262 filings | Aug 14, 2026 | SEC |
| Suvretta Capital Management, LLC | 13G | 5.10%4.22M shares | New | May 12, 20261 filing | May 12, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
15 Schedule 13D and 13G filings on Replimune Group, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20264:00 PM ET | Ridgeback Capital Investments L.P.and 2 others | 13G/A | 8.70%7.31M shares | +1.10 ppfrom 7.60% | Jun 30, 2026 | SEC |
| May 21, 20265:24 PM ET | Ridgeback Capital Investments L.P.and 2 others | 13G | 7.60%6.25M shares | New | May 14, 2026 | SEC |
| May 15, 20268:30 AM ET | RTW Investments, LPand 1 other | 13G/A | 8.90%7.36M shares | +0.70 ppfrom 8.20% | Mar 31, 2026 | SEC |
| May 12, 20266:32 PM ET | Suvretta Capital Management, LLCand 1 other | 13G | 5.10%4.22M shares | New | Mar 31, 2026 | SEC |
| May 7, 202611:04 AM ET | Price T Rowe Associates Inc | 13G/A | 0.20%158.0K shares | −10.40 ppfrom 10.60%Below 5% | Apr 30, 2026 | SEC |
| Feb 17, 20268:28 AM ET | Forbion Capital Fund III Cooperatief U.A.and 1 other | 13G/A | 3.50%2.81M shares | −2.60 ppfrom 6.10%Below 5% | Dec 31, 2025 | SEC |
| Nov 14, 20254:15 PM ET | Redmile Group, LLCand 1 other | 13G/A | 0.70%535.8K shares | −5.70 ppfrom 6.40%Below 5% | Sep 30, 2025 | SEC |
| Nov 14, 20254:12 PM ET | Point72 Asset Management, L.P.and 2 others | 13G/A | 4.70%3.63M shares | −1.00 ppfrom 5.70%Below 5% | Sep 30, 2025 | SEC |
| Nov 14, 202512:19 PM ET | Price T Rowe Associates Inc | 13G/A | 10.60%8.31M shares | – | Sep 30, 2025 | SEC |
| Nov 14, 20258:31 AM ET | RTW Investments, LPand 1 other | 13G | 8.20%6.40M shares | New | Sep 30, 2025 | SEC |
| Jul 31, 20254:05 PM ET | Point72 Asset Management, L.P.and 2 others | 13G | 5.70%4.46M shares | New | Jul 30, 2025 | SEC |
| May 15, 20259:01 PM ET | Redmile Group, LLCand 1 other | 13G/A | 6.40%4.90M shares | – | Mar 31, 2025 | SEC |
| Mar 7, 20255:07 PM ET | Baker Bros. Advisors LPand 3 others | 13D | 14.30%11.0M shares | New | Mar 7, 2025 | SEC |
| Feb 14, 20259:00 AM ET | Forbion Capital Fund III Cooperatief U.A.and 1 other | 13G/A | 6.10%4.22M shares | – | Dec 31, 2024 | SEC |
| Jan 31, 20259:55 AM ET | Vanguard Group Inc | 13G/A | 4.77%3.60M shares | –Below 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Replimune Group, Inc. shares.
No Form 144 notices for Replimune Group, Inc. are on file.